Halozyme Therapeutics Stock Overlap Studies Triple Exponential Moving Average

HALO Stock  USD 48.20  0.27  0.56%   
Halozyme Therapeutics overlap studies tool provides the execution environment for running the Triple Exponential Moving Average study and other technical functions against Halozyme Therapeutics. Halozyme Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Triple Exponential Moving Average study function is designed to identify and follow existing trends. Halozyme Therapeutics overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was twenty-seven with a total number of output elements of thirty-four. Halozyme Therapeutics Triple Exponential Moving Average indicator shows smoothing effect of Halozyme Therapeutics price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Halozyme Therapeutics Technical Analysis Modules

Most technical analysis of Halozyme Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Halozyme from various momentum indicators to cycle indicators. When you analyze Halozyme charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Halozyme Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Halozyme Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Halozyme Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Halozyme Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Halozyme Therapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Halozyme Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Halozyme Therapeutics, we also check how macroeconomic factors affect Halozyme Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Payables Turnover52.837.8716.2817.09
Days Of Inventory On Hand241.69262.34242.12230.01
Hype
Prediction
LowEstimatedHigh
43.7247.5251.32
Details
Intrinsic
Valuation
LowRealHigh
44.5648.3652.16
Details
10 Analysts
Consensus
LowTargetHigh
47.2351.9057.61
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.011.031.05
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Halozyme Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Halozyme Therapeutics' short interest history, or implied volatility extrapolated from Halozyme Therapeutics options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
FinTech Idea
FinTech
Invested over 60 shares
Business Services Idea
Business Services
Invested few shares
Power Assets Idea
Power Assets
Invested over 200 shares
Momentum Idea
Momentum
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
When determining whether Halozyme Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Halozyme Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Halozyme Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Halozyme Therapeutics Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Halozyme Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
To learn how to invest in Halozyme Stock, please use our How to Invest in Halozyme Therapeutics guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Halozyme Therapeutics. If investors know Halozyme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Halozyme Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.721
Earnings Share
3.02
Revenue Per Share
7.431
Quarterly Revenue Growth
0.343
Return On Assets
0.1487
The market value of Halozyme Therapeutics is measured differently than its book value, which is the value of Halozyme that is recorded on the company's balance sheet. Investors also form their own opinion of Halozyme Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Halozyme Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Halozyme Therapeutics' market value can be influenced by many factors that don't directly affect Halozyme Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Halozyme Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Halozyme Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Halozyme Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.